A critical review of the evidence supporting aldosterone in the etiology and its blockade in the treatment of obesity-associated hypertension

Narrative Review: The Emerging Clinical Implications of the Role of Aldosterone in the Metabolic Syndrome and Resistant Hypertension

(2013) James R. Sowers   ANNALS OF INTERNAL MEDICINE

Mineralocorticoid Receptor-Associated Hypertension and Its Organ Damage: Clinical Relevance for Resistant Hypertension

(2012) H. Shibata et al.   AMERICAN JOURNAL OF HYPERTENSION

Plasma Aldosterone Is Increased in Class 2 and 3 Obese Essential Hypertensive Patients Despite Drug Treatment

(2012) R. Sarzani et al.   AMERICAN JOURNAL OF HYPERTENSION

Adipocytes Produce Aldosterone Through Calcineurin-Dependent Signaling Pathways

(2012) Ana M. Briones et al.   HYPERTENSION

Prevalence of Obesity and Trends in the Distribution of Body Mass Index Among US Adults, 1999-2010

(2012) Katherine M. Flegal et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Correlation of renin angiotensin and aldosterone system activity with subcutaneous and visceral adiposity: the framingham heart study

(2012) Conall M O'Seaghdha et al.   BMC Endocrine Disorders

Adipocyte-specific deficiency of angiotensinogen decreases plasma angiotensinogen concentration and systolic blood pressure in mice

(2011) Frederique Yiannikouris et al.   AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY

Addition of Spironolactone in Patients With Resistant Arterial Hypertension (ASPIRANT)

(2011) Jan Václavík et al.   HYPERTENSION

Rac1 GTPase in rodent kidneys is essential for salt-sensitive hypertension via a mineralocorticoid receptor–dependent pathway

(2011) Shigeru Shibata et al.   JOURNAL OF CLINICAL INVESTIGATION

Spironolactone for difficult to control hypertension in chronic kidney disease: an analysis of safety and efficacy

(2010) Jodi Heshka et al.   Journal of the American Society of Hypertension

Efficacy of Spironolactone Therapy in Patients With True Resistant Hypertension

(2009) Fabio de Souza et al.   HYPERTENSION

Plasma Aldosterone and Its Relationships With Left Ventricular Mass in Essential Hypertensive Patients With the Metabolic Syndrome

(2008) G. Mule et al.   AMERICAN JOURNAL OF HYPERTENSION

ACE2 is expressed in mouse adipocytes and regulated by a high-fat diet

(2008) Manisha Gupte et al.   AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY

A novel adipokine CTRP1 stimulates aldosterone production

(2008) Jun Ho Jeon et al.   FASEB JOURNAL

Variety of Angiotensin Receptors in 3T3-L1 Preadipose Cells and Differentiated Adipocytes

(2008) F. Weiland et al.   HORMONE AND METABOLIC RESEARCH

Resistant Hypertension: Diagnosis, Evaluation, and Treatment

(2008) David A. Calhoun et al.   HYPERTENSION

Body Mass Index Predicts Plasma Aldosterone Concentrations in Overweight-Obese Primary Hypertensive Patients

(2008) Gian Paolo Rossi et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Effectiveness of the selective aldosterone blocker, eplerenone, in patients with resistant hypertension

(2008) David A. Calhoun et al.   Journal of the American Society of Hypertension

Modification of mineralocorticoid receptor function by Rac1 GTPase: implication in proteinuric kidney disease

(2008) Shigeru Shibata et al.   NATURE MEDICINE

Effect of weight loss through laparoscopic gastric banding on blood pressure, plasma renin activity and aldosterone levels in morbid obesity

(2008) C. Dall'Asta et al.   NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES